Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence Immunoassay
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Jiang-Yang Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: ATGC Inc., King of Prussia, PA, United States. Hauptthemen laut MEDLINE: Fentanyl, Luminescent Measurements. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
Background
Abuse of fentanyl and its analogs is a major contributor to the opioid overdose epidemic in the United States, but detecting and quantifying trace amounts of such drugs remains a challenge without resorting to sophisticated mass spectrometry-based methods.
Methods
A sensitive immunoassay with a sub-picogram limit of detection for fentanyl and a wide range of fentanyl analogs has been developed, using a novel high-affinity antibody fused with NanoLuc, a small-size luciferase that can emit strong and stable luminescence. When used with human urine samples, the assay has a sub-picogram limit of detection for fentanyl, with results fully concordant with LC-MS.
Results
When applied to clinical samples, the novel chemiluminescence immunoassay can detect low positive fentanyl missed by routine screening immunoassays, with a limit of detection of 0.8 pg/mL in human urine. When applied to environmental samples, the assay can detect levels as low as 0.25 pg fentanyl per inch2 of environment surface. Assay turnaround time is less than 1 h, with inexpensive equipment and the potential for high-throughput automation or in-field screening.
Conclusions
We have established a novel assay that may have broad applications in clinical, environmental, occupational, and forensic scenarios for detection of trace amounts of fentanyl and its analogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ATGC Inc., King of Prussia, PA, United States.
- Instanosis Inc., King of Prussia, PA, United States.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Förderung
- NIDA NIH HHS
Zitieren
APA
Zhao, J. Y., Uddin, M., Unsihuay, D., Butler, W., Xia, T. W., Xu, J. Z., Wang, S., Sheng, X., Jannetto, P. J., Wang, P., & Xia, X. (2024). Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence Immunoassay. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae071
Vancouver
Zhao JY, Uddin M, Unsihuay D, Butler W, Xia TW, Xu JZ, et al. Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence Immunoassay. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae071
BibTeX
@article{Zhao2024,
author = {Zhao, Jiang-Yang and Uddin, Mezbah and Unsihuay, Daisy and Butler, William and Xia, Terrance W and Xu, Jayson Z and Wang, Simon and Sheng, Xiaolin and Jannetto, Paul J and Wang, Ping and Xia, Xiaofeng},
title = {Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence Immunoassay},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae071}
}
EUVIMED